Prudential Financial
RPRX icon

Prudential Financial’s Royalty Pharma RPRX Stock Holding History

Prudential Financial’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$517K Buy
9,220
+450
+5% +$23.4K ﹤0.01% 1897
2026
Q1 		$421K Sell
8,770
-1,852
-17% -$81.1K ﹤0.01% 1918
2025
Q4 		$410K Sell
10,622
-208
-2% -$7.93K ﹤0.01% 1893
2025
Q3 		$382K Sell
10,830
-186
-2% -$6.73K ﹤0.01% 2031
2025
Q2 		$397K Sell
11,016
-8,911
-45% -$295K ﹤0.01% 2014
2025
Q1 		$620K Buy
19,927
+1,567
+9% +$49.7K ﹤0.01% 1749
2024
Q4 		$488K Sell
18,360
-955
-5% -$25.3K ﹤0.01% 1842
2024
Q3 		$546K Sell
19,315
-1,769
-8% -$49K ﹤0.01% 2178
2024
Q2 		$556K Buy
21,084
+3,000
+17% +$83.2K ﹤0.01% 2127
2024
Q1 		$549K Buy
18,084
+5,774
+47% +$170K ﹤0.01% 2135
2023
Q4 		$346K Sell
12,310
-2,600
-17% -$71.5K ﹤0.01% 2274
2023
Q3 		$405K Sell
14,910
-400
-3% -$11.9K ﹤0.01% 2154
2023
Q2 		$471K Buy
15,310
+4,800
+46% +$163K ﹤0.01% 2151
2023
Q1 		$379K Hold
10,510
– – ﹤0.01% 2190
2022
Q4 		$415K Sell
10,510
-3,835
-27% -$160K ﹤0.01% 2104
2022
Q3 		$576K Buy
14,345
+3,010
+27% +$129K ﹤0.01% 2012
2022
Q2 		$477K Sell
11,335
-9,085
-44% -$372K ﹤0.01% 2158
2022
Q1 		$796K Sell
20,420
-12,565
-38% -$493K ﹤0.01% 1985
2021
Q4 		$1.31M Buy
32,985
+13,220
+67% +$514K ﹤0.01% 1747
2021
Q3 		$714K Buy
19,765
+9,900
+100% +$385K ﹤0.01% 1980
2021
Q2 		$404K Buy
9,865
+1,645
+20% +$70K ﹤0.01% 2205
2021
Q1 		$359K Buy
+8,220
New +$390K ﹤0.01% 2230

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Prudential Financial's RPRX Position: Q2 2026 in Review

Prudential Financial increased its Royalty Pharma (RPRX) stake by 5.1% in Q2 2026, buying an estimated $23.4K and bringing the position to 9,220 shares worth $517K. The position accounts for ﹤0.01% of the portfolio, ranked #1897.

Prudential Financial first reported a position in RPRX in Q1 2021 and has held it in 22 quarters since. The position peaked at $1.31M in Q4 2021. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Prudential Financial held 9,220 shares of Royalty Pharma worth $517K as of Q2 2026.
  • Prudential Financial bought 450 Royalty Pharma shares in Q2 2026, an estimated $23.4K.
  • Royalty Pharma made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #1897 holding.
  • Prudential Financial first reported a position in Royalty Pharma in Q1 2021 and has held it in 22 quarters since.
  • Prudential Financial's Royalty Pharma position peaked at $1.31M in Q4 2021.
  • 645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.